USP General Chapter <825> Impact on Nuclear Medicine Technology Practice
| Autor: | George H. Hinkle |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Radiological and Ultrasound Technology
business.industry Organizations Nonprofit technology industry and agriculture MEDLINE Continuing education Pharmacy General Medicine Audit equipment and supplies United States 030218 nuclear medicine & medical imaging Benchmarking 03 medical and health sciences 0302 clinical medicine Current practice Humans Radiology Nuclear Medicine and imaging Business Nuclear Medicine Nuclear medicine hormones hormone substitutes and hormone antagonists Repackaging Accreditation |
| Zdroj: | Journal of Nuclear Medicine Technology. 48:106-113 |
| ISSN: | 1535-5675 0091-4916 |
| Popis: | U.S. Pharmacopeia (USP) general chapter825, "Radiopharmaceuticals: Preparation, Compounding, Dispensing, and Repackaging," is a new standard proposed to provide minimum requirements for the preparation, compounding, dispensing, and repackaging of sterile and nonsterile radiopharmaceuticals. This new standard represents endeavors on the part of the USP to respond to appeals by nuclear medicine professionals to move beyond a minimal supplement to USP797and provide policies specific to radiopharmaceuticals. USP825provides nuclear pharmacies and nuclear medicine departments in hospitals and clinics with the benchmarks to assess current practice activities and integrate needed changes to meet regulatory and accreditation audit reviews. This continuing education article focuses on components of USP825specific to the nuclear medicine technologist for a better understanding of obligations when preparing sterile radiopharmaceuticals for clinical use. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|